Tag: viral diagnostic test kits market players

  • Viral Diagnostic Test Kits Market Forecast Highlights A $24.87 Billion Opportunity For Industry Participants

    Viral Diagnostic Test Kits Market Forecast Highlights A $24.87 Billion Opportunity For Industry Participants

    Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

    Viral Diagnostic Test Kits Market Expansion Outlook: What Revenue Opportunities Are Ahead?

    The viral diagnostic test kits market has experienced robust growth in recent years. It is projected to increase from $17.48 billion in 2025 to $18.88 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.0%. The growth observed in prior periods can be linked to recurring outbreaks of viral infections, the expansion of clinical diagnostic laboratories, a greater adoption of PCR-based testing, an increasing demand for early disease detection, and improvements in laboratory infrastructure.

    The viral diagnostic test kits market size is anticipated to experience robust expansion over the coming years. This market is projected to reach $24.87 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. Factors contributing to this growth during the forecast period include enhanced readiness for potential pandemics, an escalating need for decentralized testing, increased capital allocated to molecular diagnostics, the proliferation of home-based testing options, and continuous technological improvements in the sensitivity and speed of assays. Key trends anticipated during this forecast timeframe encompass a wider embrace of rapid diagnostic test kits, a surge in the application of molecular methods for viral detection, an increasing call for point-of-care testing products, an increase in the creation of multiplex viral assays, and a stronger emphasis on diagnostic precision with high sensitivity.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=73794572&type=smp&name=Viral%20Diagnostic%20Test%20Kits%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Viral Diagnostic Test Kits Market Development Factors: What’s Supporting Demand?

    An increasing incidence of viral infections is anticipated to boost the expansion of the viral diagnostic test kits market in the future. These infections stem from microscopic viruses infiltrating and multiplying within host cells, potentially causing a spectrum of health issues from minor sicknesses to critical, life-threatening states. The increase in viral infections is propelled by elements like worldwide travel, increasing urbanization, unsafe injection methods, and inadequate access to prompt diagnosis and necessary treatment. Viral diagnostic test kits, designed to identify viral nucleic acids (RNA or DNA), antigens, or antibodies present in biological specimens like blood or swabs, play a vital role in recognizing infections, informing treatment choices, and managing disease outbreaks. For example, reports from April 2025 by the Centers for Disease Control and Prevention (CDC), a US federal agency, indicated 2,214 new acute hepatitis B cases in 2023, which represents an estimated 14,400 infections when accounting for underreporting, along with 17,650 newly reported chronic hepatitis B cases. The same document further revealed 4,966 new acute hepatitis C cases and 101,525 new chronic hepatitis C cases in 2023. Consequently, the escalating occurrence of viral infections is acting as a primary catalyst for the expansion of the viral diagnostic test kits market.

    Viral Diagnostic Test Kits Market Segment Trends And Revenue Contributors

    The viral diagnostic test kits market covered in this report is segmented –

    1) By Testing Approach: Traditional Tests, Rapid Test

    2) By Test Type: Direct Fluorescent Antibody (DFA) Test, Immunochromatographic Assay, Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Test, Agglutination Assay, Solid Phase Assay, Flow Through Assay, Other Test Types

    3) By End-User: Research Laboratories, Clinics, Hospitals, Other End Users

    Subsegments:

    1) By Traditional Tests: Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR) Tests, Western Blot, Viral Culture Testing

    2) By Rapid Test: Lateral Flow Assays (LFA), Immunochromatographic Strip Tests, Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP), Rapid Antigen Tests

    Viral Diagnostic Test Kits Market Transformation Trends: What Innovations Are Driving Change?

    Leading companies in the viral diagnostic test kits market are creating advanced products, such as virus detection kits, to maintain their market presence. A virus detection kit is a diagnostic instrument crafted to identify specific viruses in biological samples, delivering quick and precise results for effective disease observation and management. For instance, in August 2024, BlueStain Global Ltd, a UK-based company, introduced an MPox virus detection kit. The Bluestain MPox virus detection kit is a rapid diagnostic assay developed to detect the mpox virus with high speed and accuracy, providing results in just 15 to 30 minutes. This innovative kit aims to bolster public health efforts by supporting early identification and control of mpox outbreaks, particularly in regions with limited resources.

    Viral Diagnostic Test Kits Market Top Companies Driving Competitive Growth

    Major companies operating in the viral diagnostic test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Ortho Clinical Diagnostics, Seegene Inc., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Trinity Biotech plc

    View The Full Viral Diagnostic Test Kits Market Report:

    https://thebusinessresearchcompany.com/report/viral-diagnostic-test-kits-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Viral Diagnostic Test Kits Market Global Footprint: Which Region Leads The Industry?

    North America was the largest region in the viral diagnostic test kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral diagnostic test kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Viral Diagnostic Test Kits Market Overview 2026–2030 With Insights On Industry Developments

    Viral Diagnostic Test Kits Market Overview 2026–2030 With Insights On Industry Developments

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Is The Forecasted Market Size Trajectory Of The Viral Diagnostic Test Kits Market From 2026 To 2030?

    The viral diagnostic test kits market size has demonstrated strong expansion in recent years. This market is projected to expand from $17.48 billion in 2025 to $18.88 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.0%. The historical growth of the market can be attributed to recurring outbreaks of viral infections, the expansion of clinical diagnostic laboratories, increased adoption of PCR-based testing, a rising demand for early disease detection, and improvements in laboratory infrastructure.

    The viral diagnostic test kits market is projected to experience substantial expansion in the coming years. This market is set to reach $24.87 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. This anticipated growth during the forecast period is driven by factors such as enhanced readiness for upcoming pandemics, a heightened need for decentralized testing, increased capital deployment in molecular diagnostics, the proliferation of home-based testing options, and innovations in assay sensitivity and speed. Key trends anticipated for the forecast timeframe involve the wider acceptance of rapid diagnostic test kits, an uptick in the application of molecular-based viral detection methods, an increasing preference for point-of-care testing solutions, the broadening scope of multiplex viral assay development, and a sharpened emphasis on achieving high-sensitivity diagnostic accuracy.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/viral-diagnostic-test-kits-global-market-report

    What Key Drivers Are Fueling The Growth Of The Viral Diagnostic Test Kits Market?

    The increasing occurrence of viral infections is anticipated to boost the expansion of the viral diagnostic test kits market. These infections, stemming from microscopic viruses that invade and multiply within host cells, can manifest as anything from minor ailments to critical conditions. Factors such as international travel, increasing urban populations, risky injection practices, and insufficient access to timely diagnosis and treatment contribute to the rise in viral infections. Viral diagnostic test kits, designed to identify viral genetic material (RNA or DNA), antigens, or antibodies in biological specimens like blood or swabs, are essential for pinpointing infections, guiding medical decisions, and managing outbreaks. For illustration, a report from the Centers for Disease Control and Prevention (CDC), a US federal agency, stated in April 2025 that there were 2,214 new acute hepatitis B cases in 2023, equating to an estimated 14,400 infections after accounting for underreporting, along with 17,650 newly reported chronic hepatitis B cases. The same document also indicated 4,966 new acute hepatitis C cases and 101,525 new chronic hepatitis C cases in 2023. Consequently, the rising frequency of viral infections is a key driver for the growth of the viral diagnostic test kits market.

    How Is Segmentation Applied In The Viral Diagnostic Test Kits Market Segment Analysis?

    The viral diagnostic test kits market covered in this report is segmented –

    1) By Testing Approach: Traditional Tests, Rapid Test

    2) By Test Type: Direct Fluorescent Antibody (DFA) Test, Immunochromatographic Assay, Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Test, Agglutination Assay, Solid Phase Assay, Flow Through Assay, Other Test Types

    3) By End-User: Research Laboratories, Clinics, Hospitals, Other End Users

    Subsegments:

    1) By Traditional Tests: Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR) Tests, Western Blot, Viral Culture Testing

    2) By Rapid Test: Lateral Flow Assays (LFA), Immunochromatographic Strip Tests, Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP), Rapid Antigen Tests

    What Trends Are Influencing The Viral Diagnostic Test Kits Market?

    Leading corporations operating in the viral diagnostic test kits market are developing innovative products, such as virus detection kits, to sustain their market position. A virus detection kit functions as a diagnostic instrument crafted to identify the presence of specific viruses within biological samples, offering swift and accurate results for effective disease monitoring and management. For example, in August 2024, BlueStain Global Ltd, a UK-based company, introduced an MPox virus detection kit. The Bluestain MPox virus detection kit is a rapid diagnostic test engineered to detect the mpox virus with high speed and accuracy, providing results in just 15 to 30 minutes. This innovative kit aims to enhance public health responses by facilitating the early detection and containment of mpox outbreaks, particularly in resource-limited environments.

    Who Are The Companies Participating In The Viral Diagnostic Test Kits Market Environment?

    Major companies operating in the viral diagnostic test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Ortho Clinical Diagnostics, Seegene Inc., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Trinity Biotech plc

    Get The Full Viral Diagnostic Test Kits Market Report:

    https://www.thebusinessresearchcompany.com/report/viral-diagnostic-test-kits-global-market-report

    Which Region Leads The Viral Diagnostic Test Kits Market In Terms Of Market Share?

    North America was the largest region in the viral diagnostic test kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral diagnostic test kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Viral Diagnostic Test Kits Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/viral-diagnostic-test-kits-global-market-report

    Browse Through More Reports Similar to the Global Viral Diagnostic Test Kits Market 2026, By The Business Research Company

    Covid 19 Rapid Test Kits Market 2026

    https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-market

    Infectious Disease Diagnostics Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

    Hospital Acquired Infections Testing Kits Market Report 2026

    https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Viral Diagnostic Test Kits Market Expected to Reach $24.86 Billion by 2030 with 7.1% CAGR

    Global Viral Diagnostic Test Kits Market Expected to Reach $24.86 Billion by 2030 with 7.1% CAGR

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Will Be The Estimated Market Valuation Of The Viral Diagnostic Test Kits Market By The End Of 2030?

    The viral diagnostic test kits market size has demonstrated strong growth in recent years. It is expected to expand from $17.48 billion in 2025 to $18.88 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.0%. The past growth in this market stems from recurrent outbreaks of viral infections, the proliferation of clinical diagnostic laboratories, increased utilization of PCR-based testing, a heightened demand for early disease detection, and improvements in laboratory infrastructure.

    The viral diagnostic test kits market size is projected to experience robust growth over the next few years. It is forecasted to expand to $24.87 billion in 2030, achieving a compound annual growth rate (CAGR) of 7.1%. This projected growth can be attributed to heightened preparedness for future pandemics, an increasing demand for decentralized testing, rising investments in molecular diagnostics, the expansion of home-based testing solutions, and technological advancements enhancing assay sensitivity and speed. Significant trends anticipated during the forecast period include the increasing adoption of rapid diagnostic test kits, a growing reliance on molecular-based viral detection, the expanding demand for point-of-care testing solutions, the development of multiplex viral assays, and an amplified focus on high-sensitivity diagnostic accuracy.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16821&type=smp

    What Drivers Are Shaping The Future Growth Of The Viral Diagnostic Test Kits Market?

    The increasing incidence of viral infections is anticipated to boost the expansion of the viral diagnostic test kits market in the future. These infections result from tiny viruses entering and multiplying within host cells, potentially causing anything from minor sickness to severe, life-threatening ailments. Several factors contribute to the surge in viral infections, including worldwide travel, increased urbanization, unsafe injection methods, and insufficient access to prompt diagnosis and medical care. Essential for identifying infections, informing treatment choices, and managing outbreaks, viral diagnostic test kits work by detecting viral nucleic acids (RNA or DNA), antigens, or antibodies present in biological samples like blood or swabs. As an illustration, in April 2025, data from the Centers for Disease Control and Prevention (CDC), a US federal agency, indicated 2,214 new acute hepatitis B cases in 2023, which translates to an estimated 14,400 infections when underreporting is considered, alongside 17,650 newly reported chronic hepatitis B cases. This same report further revealed 4,966 new acute hepatitis C cases and 101,525 new chronic hepatitis C cases in 2023. Consequently, the increasing prevalence of viral infections serves as a primary driver for the expansion of the viral diagnostic test kits market.

    Which Segment Classifications Shape The Viral Diagnostic Test Kits Market?

    The viral diagnostic test kits market covered in this report is segmented –

    1) By Testing Approach: Traditional Tests, Rapid Test

    2) By Test Type: Direct Fluorescent Antibody (DFA) Test, Immunochromatographic Assay, Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Test, Agglutination Assay, Solid Phase Assay, Flow Through Assay, Other Test Types

    3) By End-User: Research Laboratories, Clinics, Hospitals, Other End Users

    Subsegments:

    1) By Traditional Tests: Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR) Tests, Western Blot, Viral Culture Testing

    2) By Rapid Test: Lateral Flow Assays (LFA), Immunochromatographic Strip Tests, Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP), Rapid Antigen Tests

    How Are Trends Impacting The Viral Diagnostic Test Kits Market?

    Leading companies in the viral diagnostic test kits market are actively developing innovative products, such as virus detection kits, to maintain their market standing. A virus detection kit serves as a diagnostic tool specifically designed to identify the presence of particular viruses in biological samples, providing quick and precise results essential for effective disease monitoring and management. Illustrating this, in August 2024, BlueStain Global Ltd, a UK-based company, launched its MPox virus detection kit. The Bluestain MPox virus detection kit operates as a rapid diagnostic test, engineered to detect the mpox virus with significant speed and accuracy, delivering results in just 15 to 30 minutes. This groundbreaking kit aims to strengthen public health responses by facilitating the early detection and containment of mpox outbreaks, especially in resource-limited settings.

    Which Companies Are Expanding Their Footprint In The Viral Diagnostic Test Kits Market?

    Major companies operating in the viral diagnostic test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Ortho Clinical Diagnostics, Seegene Inc., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Trinity Biotech plc

    Read the full viral diagnostic test kits market report here:

    https://www.thebusinessresearchcompany.com/report/viral-diagnostic-test-kits-global-market-report

    Which Geographic Regions Are Influencing Demand In The Viral Diagnostic Test Kits Market?

    North America was the largest region in the viral diagnostic test kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral diagnostic test kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Viral Diagnostic Test Kits Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=16821&type=smp

    Browse Through More Reports Similar to the Global Viral Diagnostic Test Kits Market 2026, By The Business Research Company

    Covid 19 Rapid Test Kits Market 2026

    https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-market

    Infectious Disease Diagnostics Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

    Hospital Acquired Infections Testing Kits Market Report 2026

    https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Viral Diagnostic Test Kits Market 2026–2030: Emerging Trends and Forecast Opportunities

    Viral Diagnostic Test Kits Market 2026–2030: Emerging Trends and Forecast Opportunities

    Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

    Starting from its 2026 valuation, what market size is the Viral Diagnostic Test Kits Market expected to reach by 2030?

    The viral diagnostic test kits market has experienced significant growth in recent years. Its value is expected to rise from $17.48 billion in 2025 to $18.88 billion in 2026, progressing at a compound annual growth rate (CAGR) of 8.0%. The historical growth of this market can be linked to recurring outbreaks of viral infections, the expansion of clinical diagnostic laboratories, increased adoption of PCR-based testing, a rising demand for early disease detection, and improvements in laboratory infrastructure.

    The viral diagnostic test kits market size is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $24.87 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. This growth throughout the forecast period stems from factors such as heightened readiness for future pandemics, an increasing need for decentralized testing, greater investments in molecular diagnostics, the broadening availability of home-based testing options, and advancements in assay sensitivity and speed due to technology. Key developments expected during this period include a greater uptake of rapid diagnostic test kits, increased reliance on molecular-based viral detection methods, a surging demand for point-of-care testing solutions, the advancement of multiplex viral assay development, and an amplified focus on diagnostic accuracy with high sensitivity.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16821&type=smp

    What Drivers Are Driving Adoption Within The Viral Diagnostic Test Kits Market?

    An increasing incidence of viral infections is anticipated to boost the expansion of the viral diagnostic test kits market in the future. These infections stem from microscopic viruses infiltrating and multiplying inside host cells, potentially resulting in conditions from minor ailments to severe, life-threatening states. The rise in viral infections is influenced by elements like international travel, urban development, hazardous injection methods, and insufficient availability of prompt diagnosis and care. Essential for identifying infections, informing treatment choices, and managing outbreaks, viral diagnostic test kits work by detecting viral nucleic acids (RNA or DNA), antigens, or antibodies within biological specimens like blood or swabs. As an illustration, a report from April 2025 by the US-based federal agency, the Centers for Disease Control and Prevention (CDC), indicated 2,214 new acute hepatitis B cases in 2023, equating to an estimated 14,400 infections when underreporting is considered, along with 17,650 newly reported chronic hepatitis B cases. Furthermore, the same document revealed 4,966 new acute hepatitis C cases and 101,525 new chronic hepatitis C cases in 2023. Consequently, the growing occurrence of viral infections is propelling the expansion of the viral diagnostic test kits market.

    How Is The Viral Diagnostic Test Kits Market Organized Into Various Segments?

    The viral diagnostic test kits market covered in this report is segmented –

    1) By Testing Approach: Traditional Tests, Rapid Test

    2) By Test Type: Direct Fluorescent Antibody (DFA) Test, Immunochromatographic Assay, Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Test, Agglutination Assay, Solid Phase Assay, Flow Through Assay, Other Test Types

    3) By End-User: Research Laboratories, Clinics, Hospitals, Other End Users

    Subsegments:

    1) By Traditional Tests: Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR) Tests, Western Blot, Viral Culture Testing

    2) By Rapid Test: Lateral Flow Assays (LFA), Immunochromatographic Strip Tests, Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP), Rapid Antigen Tests

    Which Trends Are Expected To Influence The Viral Diagnostic Test Kits Market In The Upcoming Years?

    Leading companies within the viral diagnostic test kits market are developing novel products, such as virus detection kits, to sustain their competitive position. A virus detection kit serves as a diagnostic instrument engineered to pinpoint particular viruses in biological specimens, yielding swift and precise outcomes crucial for proficient disease surveillance and control. As an illustration, in August 2024, BlueStain Global Ltd, a company headquartered in the UK, introduced an MPox virus detection kit. The BlueStain MPox virus detection kit represents a swift diagnostic examination crafted to identify the mpox virus with impressive rapidity and precision, furnishing results within a mere 15 to 30 minutes. This groundbreaking kit aims to bolster public health initiatives by enabling prompt discovery and limitation of mpox epidemics, especially beneficial in environments with constrained resources.

    Who Are The Core Companies Influencing Trends In The Viral Diagnostic Test Kits Market?

    Major companies operating in the viral diagnostic test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Ortho Clinical Diagnostics, Seegene Inc., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Trinity Biotech plc

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/viral-diagnostic-test-kits-global-market-report

    Which Region Is Projected To Lead The Viral Diagnostic Test Kits Market During The Forecast Period?

    North America was the largest region in the viral diagnostic test kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral diagnostic test kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Viral Diagnostic Test Kits Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=16821&type=smp

    Browse Through More Reports Similar to the Global Viral Diagnostic Test Kits Market 2026, By The Business Research Company

    Covid 19 Rapid Test Kits Market 2026

    https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-market

    Infectious Disease Diagnostics Testing Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

    Hospital Acquired Infections Testing Kits Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

  • Global Viral Diagnostic Test Kits Market Size and Forecast to 2029: Revenue, Growth, and Trends

    Global Viral Diagnostic Test Kits Market Size and Forecast to 2029: Revenue, Growth, and Trends

    Uncover key drivers, emerging technologies, and competitive movements shaping the viral diagnostic test kits market from 2025–2034 with trusted insights from The Business Research Company

    How Big Is The Viral Diagnostic Test Kits Market Size Today And What Will Its Value Be At The End Of 2029?

    The market for viral diagnostic test kits has experienced robust expansion in recent years. Its valuation is projected to increase from $16.26 billion in 2024 to $17.48 billion in 2025, advancing at a compound annual growth rate (CAGR) of 7.5%. Historically, this growth has been fueled by factors such as increasing healthcare expenditure, a rise in global travel, an increase in chronic viral infections, growing demand for home testing kits, and the development of personalized medicine.

    The viral diagnostic test kits market is anticipated to experience substantial growth over the coming years, with its value projected to reach $23.4 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.6%. This expansion during the forecast period can be attributed to several factors, including an increase in Ebola virus infections, a rise in hemorrhagic fever, the growing prevalence of viral infections, an increasing incidence of respiratory syncytial virus, and the expanding prevalence of hepatitis. Furthermore, key trends expected in this period include technological advancements, the adoption of point-of-care testing, the application of AI and data analytics, enhanced integration with digital health records, and the emergence of next-generation sequencing.

    Access A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16821&type=smp

    Which Key Drivers Are Powering Growth In The Viral Diagnostic Test Kits Market?

    The viral diagnostic test kits market is expected to grow as a result of the increasing occurrence of viral infections. Viral infections originate from microscopic viruses that invade and multiply within host cells, potentially leading to a wide range of symptoms, from minor to severe, affecting various parts of the body. The rise in viral infection incidence is attributed to global travel, urbanization, climate change impacting vector-borne diseases, and the evolution of viral strains that can initiate new outbreaks or spread to new geographical areas. Viral diagnostic test kits are essential for identifying and confirming specific viral infections in patients by detecting viral nucleic acids (RNA or DNA), antigens, or antibodies in biological samples such as blood, saliva, or nasal swabs. For example, data from the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, indicates that in 2022, 2,126 new cases of acute hepatitis B were reported, alongside 16,729 newly reported cases of chronic hepatitis B. Additionally, during that same period, 14 jurisdictions in the US recorded rates of acute hepatitis B exceeding the national average in the United States. Therefore, the increasing prevalence of viral infections is driving the growth of the viral diagnostic test kits market.

    Which Segment Categories Are Driving Maximum Growth In The Viral Diagnostic Test Kits Market?

    The viral diagnostic test kitsmarket covered in this report is segmented –

    1) By Test: Traditional Tests, Rapid Test

    2) By Test Type: Direct Fluorescent Antibody (DFA) Test, Immunochromatographic Assay, Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Test, Agglutination Assay, Solid Phase Assay, Flow Through Assay, Other Test Types

    3) By End-User: Research Laboratories, Clinics, Hospitals, Other End Users

    Subsegments:

    1) By Traditional Tests: Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR) Tests, Western Blot, Viral Culture Testing

    2) By Rapid Test: Lateral Flow Assays (LFA), Immunochromatographic Strip Tests, Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP), Rapid Antigen Tests

    Which Emerging Trends Are Reshaping The Viral Diagnostic Test Kits Market Landscape?

    Leading companies in the viral diagnostic test kits market are developing inventive products, such as virus detection kits, to maintain their market position. A virus detection kit is a diagnostic instrument crafted to pinpoint the presence of particular viruses in biological samples, providing quick and precise results essential for effective disease monitoring and management. For instance, in August 2024, BlueStain Global Ltd, a UK-based company, launched an MPox virus detection kit. The Bluestain MPox virus detection kit is a rapid diagnostic test engineered to identify the mpox virus with great speed and accuracy, delivering outcomes in only 15 to 30 minutes. This groundbreaking kit is designed to improve public health responses by facilitating early identification and control of mpox outbreaks, particularly in settings with restricted resources.

    Who Are The Leading Companies Driving The Viral Diagnostic Test Kits Market?

    Major companies operating in the viral diagnostic test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Ortho Clinical Diagnostics, Myriad Genetics Inc., Seegene Inc., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Trinity Biotech plc, Biodesix Inc.

    Download The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/viral-diagnostic-test-kits-global-market-report

    Which Region Holds The Largest Share In The Viral Diagnostic Test Kits Market Today?

    North America was the largest region in the viral diagnostic test kits market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral diagnostic test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get A Report Customized For You Here:

    https://www.thebusinessresearchcompany.com/customise?id=16821&type=smp

    Browse Through More Reports Similar to the Global Viral Diagnostic Test Kits Market 2025, By The Business Research Company

    Covid 19 Detection Test Kits And Consumables Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/covid-19-detection-test-kits-and-consumables-global-market-report

    Covid 19 Rapid Test Kits Market 2025

    https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-market

    Covid 19 Rapid Test Kits Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Viral Diagnostic Test Kits Industry Anticipated to Expand at 7.6% CAGR During the Forecast Period

    Viral Diagnostic Test Kits Industry Anticipated to Expand at 7.6% CAGR During the Forecast Period

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    What Is The Predicted Market Size Trajectory For The Viral Diagnostic Test Kits Market From 2025 To 2034?

    The viral diagnostic test kits market size has grown strongly in recent years. It will grow from $16.26 billion in 2024 to $17.48 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing healthcare expenditure, increasing global travel, a rise in chronic viral infections, a rise in demand for home testing kits, and growth in personalized medicine.

    The viral diagnostic test kits market size is expected to see strong growth in the next few years. It will grow to $23.4 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing Ebola virus infections, increasing hemorrhagic fever, rising prevalence of viral infections, increasing prevalence of respiratory syncytial virus, and increasing prevalence of hepatitis. Major trends in the forecast period include technological advancements, point-of-care testing, AI and data analytics, integration with digital health records, and next-generation sequencing.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16821&type=smp

    Which Factors And Drivers Are Influencing The Viral Diagnostic Test Kits Market In 2025?

    The rising prevalence of viral infections is expected to propel the growth of the viral diagnostic test kits market going forward. Viral infections are caused by microscopic viruses that invade host cells, replicate within them, and can lead to a broad spectrum of symptoms ranging from mild to severe across different body parts. The incidence of viral infections is increasing due to global travel, urbanization, climate change influencing vector-borne diseases, and evolving viral strains that can cause new outbreaks or expand into new geographical regions. Viral diagnostic test kits are instrumental in identifying and confirming the presence of specific viral infections in patients by detecting viral nucleic acids (RNA or DNA), antigens, or antibodies in biological samples such as blood, saliva, or nasal swabs. For instance, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, in 2022, there were 2,126 new cases of acute hepatitis B reported, alongside 16,729 newly reported cases of chronic hepatitis B. Further, in the period, 14 jurisdictions in the US reported rates of acute hepatitis B higher than the national average in the United States. Therefore, the rising prevalence of viral infections is driving the growth of the viral diagnostic test kits market.

    What Are The Primary Types Of Segments Analyzed In The Viral Diagnostic Test Kits Market?

    The viral diagnostic test kitsmarket covered in this report is segmented –

    1) By Test: Traditional Tests, Rapid Test

    2) By Test Type: Direct Fluorescent Antibody (DFA) Test, Immunochromatographic Assay, Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Test, Agglutination Assay, Solid Phase Assay, Flow Through Assay, Other Test Types

    3) By End-User: Research Laboratories, Clinics, Hospitals, Other End Users

    Subsegments:

    1) By Traditional Tests: Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR) Tests, Western Blot, Viral Culture Testing

    2) By Rapid Test: Lateral Flow Assays (LFA), Immunochromatographic Strip Tests, Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP), Rapid Antigen Tests

    Which Trends Are Impacting The Viral Diagnostic Test Kits Market?

    Major companies operating in the viral diagnostic test kits market are developing innovative products, such as virus detection kit to sustain their position in the market. A virus detection kit refers to a diagnostic tool designed to identify the presence of specific viruses in biological samples, providing rapid and accurate results for effective disease monitoring and management. For instance, in August 2024, BlueStain Global Ltd, a UK-based company, launched MPox virus detection kit. The Bluestain MPox virus detection kit is a rapid diagnostic test designed to detect the mpox virus with high speed and accuracy, delivering results in just 15 to 30 minutes. This innovative kit is intended to enhance public health responses by facilitating early detection and containment of mpox outbreaks, particularly in resource-limited settings.

    Who Are The Major Companies Operating In The Viral Diagnostic Test Kits Market?

    Major companies operating in the viral diagnostic test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Ortho Clinical Diagnostics, Myriad Genetics Inc., Seegene Inc., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Trinity Biotech plc, Biodesix Inc.

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/viral-diagnostic-test-kits-global-market-report

    Which Region Currently Holds The Largest Share Of The Viral Diagnostic Test Kits Market?

    North America was the largest region in the viral diagnostic test kits market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral diagnostic test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Version Of The Viral Diagnostic Test Kits Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=16821&type=smp

    Browse Through More Reports Similar to the Global Viral Diagnostic Test Kits Market 2025, By The Business Research Company

    Covid 19 Detection Test Kits And Consumables Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/covid-19-detection-test-kits-and-consumables-global-market-report

    Covid 19 Rapid Test Kits Market 2025

    https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-market

    Covid 19 Rapid Test Kits Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • $23.4 Billion Forecast for Viral Diagnostic Test Kits Market by 2029, Backed by Demand and Innovation

    $23.4 Billion Forecast for Viral Diagnostic Test Kits Market by 2029, Backed by Demand and Innovation

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Has The Viral Diagnostic Test Kits Market Growth Evolved From 2024 To 2025, And What’s Ahead?

    The market for viral diagnostic test kits has experienced robust growth in the past years. The market projection shows an increase from $16.26 billion in 2024 to $17.48 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.5%. The upward trend in the past can be linked to factors like heightened healthcare spending, more global travel, an upsurge in chronic viral illnesses, a higher demand for home-based testing kits, and the growth of personalized medicine.

    Expectations of strong growth in the market size of viral diagnostic test kits are high for the upcoming years, with predictions of it reaching $23.4 billion by 2029 at a compound annual growth rate of 7.6%. The projected growth for this timeframe is anticipated to be a result of an upswing in Ebola virus infections, increased cases of hemorrhagic fever, a growing incidence of viral infections, surging cases of respiratory syncytial virus, and a rise in hepatitis prevalence. Key trends for the forecast period encompass technological evolutions, point-of-care testing, the use of AI and data analytics, integration into digital health records, and next-generation sequencing.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16821&type=smp

    What Are the Core Growth Drivers Propelling the Viral Diagnostic Test Kits Market Forward?

    The surge in viral infections is foreseen to accelerate the expansion of the viral diagnostic test kits market in the future. These infections, caused by minuscule viruses that replicate within host cells, prompt a wide array of mild to severe symptoms spanning various body areas. The rate of viral infections is on the rise due to factors such as worldwide travel, urbanization, climate change-induced vector-borne diseases, and the evolution of virus strains potentially leading to fresh outbreaks or infiltrating new regions. Viral diagnostic test kits play a crucial role in determining and verifying the existence of specific viral infections in individuals by tracing viral nucleic acids (RNA or DNA), antigens, or antibodies in bio-samples like blood, saliva, or nasal swabs. As an example, the Centers for Disease Control and Prevention (CDC), a national public health organization based in the US, reported 2,126 new acute hepatitis B cases in 2022, along with an additional 16,729 chronic hepatitis B cases. Moreover, during this period, 14 jurisdictions within the US reported an incidence rate of acute hepatitis B above the national US average. Hence, the escalating prevalence of viral infections is fueling the viral diagnostic test kits market’s growth.

    What Segment Types Define the Viral Diagnostic Test Kits Market Structure?

    The viral diagnostic test kitsmarket covered in this report is segmented –

    1) By Test: Traditional Tests, Rapid Test

    2) By Test Type: Direct Fluorescent Antibody (DFA) Test, Immunochromatographic Assay, Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Test, Agglutination Assay, Solid Phase Assay, Flow Through Assay, Other Test Types

    3) By End-User: Research Laboratories, Clinics, Hospitals, Other End Users

    Subsegments:

    1) By Traditional Tests: Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR) Tests, Western Blot, Viral Culture Testing

    2) By Rapid Test: Lateral Flow Assays (LFA), Immunochromatographic Strip Tests, Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP), Rapid Antigen Tests

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=16821&type=smp

    Which Geographic Areas Hold the Strongest Growth Potential in the Viral Diagnostic Test Kits Market?

    North America was the largest region in the viral diagnostic test kits market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral diagnostic test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Which Emerging Trends that Are Influencing theViral Diagnostic Test Kits Industry Evolution?

    Key players in the viral diagnostic test kits market are pioneering new products such as virus detection kits in order to maintain their market standing. The term ‘virus detection kit’ refers to a diagnostic instrument which can identify specific viruses present in biological specimens, allowing for swift and precise results, thus effectively keeping track of and managing diseases. For example, in August 2024, BlueStain Global Ltd, a company based in the UK, introduced the MPox virus detection kit. The Bluestain MPox virus detection kit is a swift diagnostic test that’s been created to recognize the mpox virus accurately and quickly, proffering results within a span of 15 to 30 minutes. The primary function of this innovative kit is to ameliorate public health interventions by hastening the early identification and mitigation of mpox epidemics, in particular, in areas with scarce resources.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/viral-diagnostic-test-kits-global-market-report

    What Is the Definition of the Viral Diagnostic Test Kits Market?

    Viral diagnostic test kits are medical devices or tools used to detect the presence of viral infections in clinical samples taken from patients. These kits typically contain reagents, antibodies, or other substances interacting with specific viral antigens or genetic material to produce a measurable signal. The tests can identify the presence of viral particles, antigens, or genetic material (like RNA or DNA) in samples such as blood, saliva, nasal swabs, or other bodily fluids.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16821

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Viral Diagnostic Test Kits Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

    Viral Diagnostic Test Kits Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    What Drivers Are Shaping the Growth and Development of theViral Diagnostic Test Kits Market?

    The rising incidence of viral infections is projected to propel the viral diagnostic test kits market. As global travel and urbanization increase, viral infections are spreading, and diagnostic kits are essential in identifying these infections. In 2022, the Centers for Disease Control and Prevention (CDC) reported 2,126 new cases of acute hepatitis B and 16,729 new chronic hepatitis B cases, indicating a need for diagnostic test kits to manage these infections.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16821&type=smp

    #How Will the CAGR of the Viral Diagnostic Test Kits Market Influence Its Overall Growth by 2034?

    The viral diagnostic test kits market size has grown strongly in recent years. It will grow from $16.26 billion in 2024 to $17.62 billion in 2025, at a compound annual growth rate (CAGR) of 8.4%. The growth in the historical period can be attributed to increasing healthcare expenditure, more global travel, a rise in chronic viral infections, increasing demand for home testing kits, and growth in personalized medicine.

    The viral diagnostic test kits market is expected to see strong growth, reaching $23.99 billion by 2029, at a CAGR of 8.0%. Growth is driven by increasing Ebola infections, hemorrhagic fever, viral infections, respiratory syncytial virus prevalence, and hepatitis. Key trends include technological advancements, point-of-care testing, AI and data analytics, digital health record integration, and next-generation sequencing.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16821

    Which Cutting-Edge Market Trends Are Expected to Drive theViral Diagnostic Test Kits Market’s Growth?

    Companies in the viral diagnostic test kits market are developing products like virus detection kits to sustain market position. For example, in August 2024, BlueStain Global Ltd. launched the MPox virus detection kit, providing rapid and accurate results for detecting the mpox virus, enhancing public health responses.

    What Are the Leading Market Players Impacting theViral Diagnostic Test Kits Market’s Growth Trend?

    Major companies operating in the viral diagnostic test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Ortho Clinical Diagnostics, Myriad Genetics Inc., Seegene Inc., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Trinity Biotech plc, Biodesix Inc.

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/viral-diagnostic-test-kits-global-market-report

    How Are the Key Segments of the Viral Diagnostic Test Kits Market Driving Opportunities and Innovations?

    The viral diagnostic test kits market covered in this report is segmented –

    1) By Test: Traditional Tests, Rapid Test

    2) By Test Type: Direct Fluorescent Antibody (DFA) Test, Immunochromatographic Assay, Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Test, Agglutination Assay, Solid Phase Assay, Flow Through Assay, Other Test Types

    3) By End-User: Research Laboratories, Clinics, Hospitals, Other End Users

    Subsegments:

    1) By Traditional Tests: Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR) Tests, Western Blot, Viral Culture Testing

    2) By Rapid Test: Lateral Flow Assays (LFA), Immunochromatographic Strip Tests, Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP), Rapid Antigen Tests

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=16821&type=smp

    What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theViral Diagnostic Test Kits Market?# Market Expansion?

    North America was the largest region in the viral diagnostic test kits market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral diagnostic test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Reports Similar to the Global Viral Diagnostic Test Kits Market 2025, By The Business Research Company:

    COVID-19 Detection Test Kits and Consumables Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/covid-19-detection-test-kits-and-consumables-global-market-report

    Anesthesia And Respiratory Devices Market Opportunities And Strategies Forecast To 2030

    https://www.thebusinessresearchcompany.com/report/anesthesia-and-respiratory-devices-market

    COVID-19 Rapid Test Kits Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Viral Diagnostic Test Kits Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

    Viral Diagnostic Test Kits Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    What Drivers Are Shaping the Growth and Development of theViral Diagnostic Test Kits Market?

    The rising incidence of viral infections is projected to propel the viral diagnostic test kits market. As global travel and urbanization increase, viral infections are spreading, and diagnostic kits are essential in identifying these infections. In 2022, the Centers for Disease Control and Prevention (CDC) reported 2,126 new cases of acute hepatitis B and 16,729 new chronic hepatitis B cases, indicating a need for diagnostic test kits to manage these infections.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16821&type=smp

    #How Will the CAGR of the Viral Diagnostic Test Kits Market Influence Its Overall Growth by 2034?

    The viral diagnostic test kits market size has grown strongly in recent years. It will grow from $16.26 billion in 2024 to $17.62 billion in 2025, at a compound annual growth rate (CAGR) of 8.4%. The growth in the historical period can be attributed to increasing healthcare expenditure, more global travel, a rise in chronic viral infections, increasing demand for home testing kits, and growth in personalized medicine.

    The viral diagnostic test kits market is expected to see strong growth, reaching $23.99 billion by 2029, at a CAGR of 8.0%. Growth is driven by increasing Ebola infections, hemorrhagic fever, viral infections, respiratory syncytial virus prevalence, and hepatitis. Key trends include technological advancements, point-of-care testing, AI and data analytics, digital health record integration, and next-generation sequencing.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16821

    Which Cutting-Edge Market Trends Are Expected to Drive theViral Diagnostic Test Kits Market’s Growth?

    Companies in the viral diagnostic test kits market are developing products like virus detection kits to sustain market position. For example, in August 2024, BlueStain Global Ltd. launched the MPox virus detection kit, providing rapid and accurate results for detecting the mpox virus, enhancing public health responses.

    What Are the Leading Market Players Impacting theViral Diagnostic Test Kits Market’s Growth Trend?

    Major companies operating in the viral diagnostic test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Ortho Clinical Diagnostics, Myriad Genetics Inc., Seegene Inc., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Trinity Biotech plc, Biodesix Inc.

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/viral-diagnostic-test-kits-global-market-report

    How Are the Key Segments of the Viral Diagnostic Test Kits Market Driving Opportunities and Innovations?

    The viral diagnostic test kits market covered in this report is segmented –

    1) By Test: Traditional Tests, Rapid Test

    2) By Test Type: Direct Fluorescent Antibody (DFA) Test, Immunochromatographic Assay, Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Test, Agglutination Assay, Solid Phase Assay, Flow Through Assay, Other Test Types

    3) By End-User: Research Laboratories, Clinics, Hospitals, Other End Users

    Subsegments:

    1) By Traditional Tests: Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR) Tests, Western Blot, Viral Culture Testing

    2) By Rapid Test: Lateral Flow Assays (LFA), Immunochromatographic Strip Tests, Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP), Rapid Antigen Tests

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=16821&type=smp

    What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theViral Diagnostic Test Kits Market?# Market Expansion?

    North America was the largest region in the viral diagnostic test kits market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral diagnostic test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Reports Similar to the Global Viral Diagnostic Test Kits Market 2025, By The Business Research Company:

    COVID-19 Detection Test Kits and Consumables Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/covid-19-detection-test-kits-and-consumables-global-market-report

    Anesthesia And Respiratory Devices Market Opportunities And Strategies Forecast To 2030

    https://www.thebusinessresearchcompany.com/report/anesthesia-and-respiratory-devices-market

    COVID-19 Rapid Test Kits Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Viral Diagnostic Test Kits Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities

    Viral Diagnostic Test Kits Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities

    Get 15% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

    How has the viral diagnostic test kits market grown in recent years?

    The market size for viral diagnostic test kits has seen significant expansion in recent years. A surge from $16.26 billion in 2024 to $17.62 billion in 2025 is anticipated, incorporating a compound annual growth rate (CAGR) of 8.4%. This upward trajectory during the past period is due to increased spending on healthcare, heightened global travel, a surge in chronic viral diseases, a growing demand for home-based testing kits, and the development of personalized medicine sectors.

    How is the viral diagnostic test kits market size expected to evolve during the forecast period?

    We anticipate robust growth in the market for viral diagnostic test kits in the coming years. The market is projected to expand to a size of $23.99 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.0%. This growth during the forecasted period can be linked to several factors such as increasing Ebola virus cases, growing cases of hemorrhagic fever, a rise in the prevalence of viral infections, an escalating number of respiratory syncytial virus cases, and an increase in hepatitis prevalence. Key trends to observe during the forecast period encompass technological progress, point-of-care testing, artificial intelligence and data analytics reliance, integration with digital health records, and the emergence of next-generation sequencing.

    Get your viral diagnostic test kits market report here!

    https://www.thebusinessresearchcompany.com/report/viral-diagnostic-test-kits-global-market-report

    Which key drivers are propelling the viral diagnostic test kits market’s growth?

    The growth of the viral diagnostic test kits market is anticipated to be driven by the increasing incidences of viral infections. These infections, caused by minute viruses that multiply within host cells, can manifest in a variety of symptoms, ranging from mild to serious, affecting various parts of the body. Factors contributing to the escalating rate of viral infections include global travel, urbanization, climate change that impacts vector-borne diseases, and the emergence of new viral strains capable of sparking fresh outbreaks or spreading into uncharted regions. Viral diagnostic test kits play a pivotal role in diagnosing and confirming specific viral infections in patients by detecting viral nucleic acids (either RNA or DNA), antigens, or antibodies in biological samples such as blood, saliva or nasal swabs. For instance, the Centers for Disease Control and Prevention (CDC), a national public health body in the US, reported that in 2022, they documented 2,126 new cases of acute hepatitis B and 16,729 new chronic hepatitis B cases. Moreover, during the period, 14 jurisdictions across the US reported acute hepatitis B rates exceeding the national average. Consequently, the escalating rate of viral infections is fueling the expansion of the viral diagnostic test kits market.

    What are the market segments in the viral diagnostic test kits industry?

    The viral diagnostic test kits market covered in this report is segmented –

    1) By Test: Traditional Tests, Rapid Test

    2) By Test Type: Direct Fluorescent Antibody (DFA) Test, Immunochromatographic Assay, Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Test, Agglutination Assay, Solid Phase Assay, Flow Through Assay, Other Test Types

    3) By End-User: Research Laboratories, Clinics, Hospitals, Other End Users

    Subsegments:

    1) By Traditional Tests: Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR) Tests, Western Blot, Viral Culture Testing

    2) By Rapid Test: Lateral Flow Assays (LFA), Immunochromatographic Strip Tests, Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP), Rapid Antigen Tests

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16821&type=smp

    Which leading companies are shaping the growth of the viral diagnostic test kits market?

    Major companies operating in the viral diagnostic test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Ortho Clinical Diagnostics, Myriad Genetics Inc., Seegene Inc., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Trinity Biotech plc, Biodesix Inc.

    What are the key trends shaping the future of the viral diagnostic test kits market?

    Leading firms in the viral diagnostic test kits market are pursuing innovative product design, such as virus detection kits, to maintain their market standing. A virus detection kit is a diagnostic tool developed to detect the presence of specific viruses in biological samples, providing prompt and precise results for effective disease management and monitoring. For example, BlueStain Global Ltd, a UK-based firm, launched a MPox virus detection kit in August 2024. The Bluestain MPox virus detection kit is a swift diagnostic test engineered to identify the mpox virus promptly and accurately, yielding results within 15 to 30 minutes. This novel kit aims to amplify public health responses by enabling early discovery and control of mpox outbreaks, particularly in areas with limited resources.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16821

    Which geographic areas are influencing the growth of the viral diagnostic test kits market?

    North America was the largest region in the viral diagnostic test kits market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral diagnostic test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Similar Reports By The Business Research Company:

    COVID-19 Detection Test Kits and Consumables Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/covid-19-detection-test-kits-and-consumables-global-market-report

    Anesthesia And Respiratory Devices Market Opportunities And Strategies Forecast To 2030

    https://www.thebusinessresearchcompany.com/report/anesthesia-and-respiratory-devices-market

    COVID-19 Rapid Test Kits Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: